Cardiac Resynchronization Therapy (CRT) Market | 2022 | Industry Share, Size, Analysis by 2027

According to the latest report by IMARC Group, titled “Cardiac Resynchronization Therapy (CRT) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, the global cardiac resynchronization therapy (CRT) market size reached US$ 4.9 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 7.2 Billion by 2027, exhibiting a growth rate (CAGR) of 6.7% during 2022-2027. 

Cardiac resynchronization therapy (CRT), also known as biventricular pacing, is a treatment used for treating arrhythmias and other disease-related abnormalities by automating right and left ventricle beating simultaneously. In order to send electric impulses into the lower chambers of the heart, the device is powered by a defibrillator, which generates a pulse. CRT devices are surgically implanted and are connected to an external computer, which sends small electrical impulses to the left and right ventricles to support simultaneous contractions. Heart failure patients who do not have their left and right heart segments pumping together will benefit from it as it improves blood flow to the heart.

Request for a PDF sample of this report: https://www.imarcgroup.com/cardiac-resynchronization-therapy-market 

Market Trends:

The global market is majorly driven by the growing incidences of cardiovascular disorders (CVDs), such as coronary heart disease, atrial fibrillation, strokes, and peripheral arterial disease, among the masses. This can be attributed to the increasing geriatric population that is more susceptible to developing these diseases. Apart from this, a considerable rise in healthcare expenditure levels across the globe is impacting the market positively. Moreover, continual technological advancements in medical product and services, along with significant improvements in the healthcare infrastructure, are creating a positive market outlook. The market is further propelled by the augmenting awareness among individuals regarding various therapeutic procedures for cardiovascular ailments. Some of the other factors contributing to the market include the introduction of MRI-safe wireless CRT devices and optimized CRT programs with multipoint pacing, the rising prevalence of sedentary lifestyles, rapid digitization in the healthcare industry, and extensive research and development (R&D) activities.

Cardiac Resynchronization Therapy (CRT) Market 2022-2027 Competitive Analysis and Segmentation:

Competitive Landscape With Key Players:

The competitive landscape of the global Cardiac resynchronization therapy (CRT) market has been studied in the report with the detailed profiles of the key players operating in the market.

Some of these Key Players Include:

• Abbott Laboratories
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• LivaNova Plc
• Medico S.p.A.
• Medtronic Plc
• Merit Medical Systems Inc.
• MicroPort Scientific Corporation.

Key Market Segmentation:

The report has segmented the global Cardiac resynchronization therapy (CRT) market on the basis of type, application and end user.

Breakup by Type:

• CRT-Defibrillator
• CRT-Pacemaker

Breakup by Application:

• Intraventricular Dyssynchrony
• Interventricular (V-V) Dyssynchrony
• Atrioventricular (A-V) Dyssynchrony

Breakup by End User:

• Hospitals
• Cardiac Centers
• Ambulatory Surgery Centers
• Others

Breakup by Region:

• North America
• Asia Pacific
• Europe
• Latin America
• Middle East and Africa

Ask Analyst for 10% Free Customized Report: https://www.imarcgroup.com/request?type=report&id=2787&flag=E                           

We are updating our reports, If you want latest primary and secondary data (2023-2028) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.

Key highlights of the report:                                                             

• Market Performance (2016-2021)
• Market Outlook (2022-2027)
• Market Trends
• Market Drivers and Success Factors
• The Impact of COVID-19 on the Global Market
• Value Chain Analysis
• Structure of the Global Market
• Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us       

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Media Contact:
Company Name: IMARC Group
Contact Person: Elena Anderson
Email: sales@imarcgroup.com
Phone: +1-631-791-1145
Address: 30 N Gould St Ste R
City: Sheridan
State: WY
Country: United States